ZYVERSA THERAPEUTICS, INC. Increase (Decrease) in Security Deposits
ZYVERSA THERAPEUTICS, INC. (ZVSA) reported Increase (Decrease) in Security Deposits of $14.48 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInSecurityDeposits · last filed 2026-05-13
- ZYVERSA THERAPEUTICS, INC. increase (decrease) in security deposits for the quarter ending 2026-03-31 was $14.48K.
- ZYVERSA THERAPEUTICS, INC. increase (decrease) in security deposits for the quarter ending 2025-12-31 was $154.88K.
- ZYVERSA THERAPEUTICS, INC. increase (decrease) in security deposits for the quarter ending 2025-09-30 was -$1.65K.
- ZYVERSA THERAPEUTICS, INC. increase (decrease) in security deposits for the quarter ending 2024-12-31 was $0.00.
- ZYVERSA THERAPEUTICS, INC. increase (decrease) in security deposits for fiscal 2025 was $161.93K.
- ZYVERSA THERAPEUTICS, INC. increase (decrease) in security deposits for fiscal 2024 was -$80.00K.
| Period end | Increase (Decrease) in Security Deposits 3 month | Increase (Decrease) in Security Deposits 6 month | Increase (Decrease) in Security Deposits 9 month | Increase (Decrease) in Security Deposits 12 month |
|---|---|---|---|---|
| 2026-03-31 | $14.48K 10-Q · filed 2026-05-13 | $169.36K derived: sum of 2 quarters · filed 2026-05-13 | $167.71K derived: sum of 3 quarters · filed 2026-05-13 | |
| 2025-12-31 | $154.88K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $153.23K derived: sum of 2 quarters · filed 2026-03-31 | $161.93K 10-K · filed 2026-03-31 | |
| 2025-09-30 | -$1.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $7.05K 10-Q · filed 2025-11-19 | ||
| 2025-06-30 | $8.70K 10-Q · filed 2025-08-13 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | -$80.00K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$80.00K 10-Q · filed 2025-11-19 | ||
| 2024-06-30 | -$80.00K 10-Q · filed 2025-08-13 | |||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $46.66K 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | $46.66K 10-Q · filed 2024-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |